共 6 条
[1]
Modification of levodopa responses by deprenyl (selegiline): an electrophysiological and behavioral study in the rat relevant to Parkinson s disease. Mercuri NB,Scarponi M,Federici M,et al. Annals of Neurology . 1998
[2]
Deprenyl decreases an endogeneous parkinsonism-inducing compound, 1 - benzyl-1, 2, 3, 4-tetrahydroisoquinoline in mice: in vivo and in vitro studies. Kotake Y,Tasaki Y,Hirobe M,et al. Brain Research . 1998
[3]
Neurology[C]. The 5th International Congress of Pathophysiology,2006
[4]
The neuroprotective and neuronal rescue effects of (-)deprenyl. Magyar K,Szende B,Lengyel J,et al. Journal of Neural Transmission . 1998
[5]
Selegiline as the primary treatment of Parkinson s disease-a long-term double-blind study. Myllyla VV,Sotaniemi KA,Hakulinen P,et al. Acta Neurologica Scandinavica . 1997
[6]
Kinigdom into excess mortality seen with combined levodopa and selegilline treatment in patients with early,mild Parkinson s disease: further results of randomized trial and confidential inquiry. Ben-shlomo Y,Churchyard A,Head J,et al. British Medical Journal . 1998